Viracta Therapeutics (RYI.F) Q3 2024 Earnings

Aug 14Confirmed
Q2 2024
Q3 2024
-0.33
-0.29
-0.25
-0.21

Details

Expected EPS
-0.33293363600000003
Actual EPS
-0.227
Surprise EPS
0.11
Surprise Percent
+31.82%

Description

⁨Viracta Therapeutics⁩ (⁦RYI.F⁩) has reported earnings of ⁦-0.227⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts